Preliminary experiments show conolidine may inhibit unique ion channels, cutting down neuronal excitability and limiting soreness signals. This system is especially suitable in neuropathic soreness, the place abnormal signaling causes persistent discomfort. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to agony perception. Computational ... https://elizabethz269qkg6.wikijournalist.com/user